Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,756 across all filing types
Latest filing 2025-07-07 Report Publication Anno…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
General Updates
Report Publication Announcement Classification · 95% confidence The document is a letter from Torrent Pharmaceuticals Limited addressed to the stock exchanges and shareholders. It discloses under SEBI Listing Regulations that the Notice of the 52nd Annual General Meeting (AGM) and the Integrated Annual Report for FY 2024-25 have been sent electronically to shareholders. The letter provides a web link to access the Annual Report and requests shareholders to update their email addresses. The document itself does not contain the full Annual Report or financial data but is an announcement about the availability of the report and the AGM notice. The document length is 3553 characters, which is relatively short and consistent with an announcement rather than the full report. Therefore, according to the MENU VS MEAL RULE, this document is a Report Publication Announcement (RPA), not the Annual Report (10-K).
2025-07-07 English
Newspaper Advertisement in respect of AGM and E-voting procedure
AGM Information Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, enclosing newspaper advertisements related to the Annual General Meeting (AGM) and e-voting procedure. It mentions the 52nd AGM and the publication of related newspaper cuttings. The document is short (1452 characters) and serves as an announcement or notification rather than the AGM materials themselves. It does not contain the AGM presentation or detailed report but rather informs about the advertisement publication. Therefore, it fits the category of AGM Information (AGM-R) as it relates to materials shared in connection with the AGM, specifically the advertisement and e-voting procedure.
2025-07-05 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the publication of newspaper advertisements about the Annual General Meeting (AGM) and the e-voting procedure. It mentions the date of the AGM and the fact that newspaper cuttings are enclosed. The document is short (1452 characters) and does not contain any financial data or detailed report content. It is an announcement related to the AGM, specifically about the advertisement and voting process, not the AGM materials themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements.
2025-07-05 English
Submission of Business Responsibility and Sustainability Report for the FY 2024-25 of the Company
Environmental & Social Information Classification · 95% confidence The document is a Business Responsibility and Sustainability Report (BRSR) for the financial year 2024-25, submitted pursuant to SEBI regulations. It includes detailed disclosures on environmental, social, and governance (ESG) factors, sustainability initiatives, and corporate social responsibility (CSR) activities. The report is explicitly described as part of the Annual Report but focuses on sustainability and responsibility aspects rather than full financial performance or management discussion. The content aligns with Environmental & Social Information filings, which cover ESG and sustainability reporting. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement. Therefore, the appropriate classification is Environmental & Social Information (SR).
2025-07-04 English
Submission of Annual Report for FY 2024-25 and intimation of voting through electronic means
Annual Report Classification · 100% confidence The document is a submission letter to stock exchanges regarding the Integrated Annual Report for the financial year 2024-25. It mentions the inclusion of the Notice calling the 52nd Annual General Meeting (AGM), Audited Financial Statements, Directors' Report, and Auditors' Report. The document also includes extensive content from the Integrated Annual Report itself, covering financial and non-financial performance, governance, sustainability, and detailed financial statements. The length is substantial (15,000 characters), and the content includes actual financial data and comprehensive reporting for the fiscal year ending March 31, 2025. Therefore, this is not merely an announcement of a report but the report itself. The document fits the definition of an Annual Report (10-K) as it covers the full fiscal year and includes audited financials and management discussion. FY 2025
2025-07-04 English
Disclosure under Regulation 30 and other applicable provisions of SEBI Listing Regulations
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding a disclosure under SEBI Listing Regulations. It details the execution of a share purchase agreement for acquiring equity shares of another company (J.B. Chemicals & Pharmaceuticals Limited) by Torrent Pharmaceuticals Limited. The content focuses on acquisition of shares, percentages of equity, and conditions such as shareholder and regulatory approvals. There is no financial statement, earnings data, or management discussion. The document is an announcement of a capital transaction related to acquisition of shares and potential controlling stake. This fits the category of Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through acquisition of shares. The document length is sufficient and contains substantive details about the transaction, not just a brief notice or report publication announcement. Therefore, the classification is CAP with high confidence.
2025-07-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.